Semler Scientific faces class action lawsuit over alleged securities violations.
PorAinvest
martes, 7 de octubre de 2025, 7:28 am ET1 min de lectura
SMLR--
According to the Complaint, Semler Scientific discussed potential violations of the False Claims Act in hypothetical terms during the class period but failed to disclose a DOJ investigation into such violations. This led to materially false and misleading statements, causing investors to suffer damages when the true details emerged. The class period for this lawsuit is from March 10, 2021, to April 15, 2025, inclusive.
Investors are urged to contact the Schall Law Firm [1], the DJS Law Group [2], and Bronstein, Gewirtz & Grossman, LLC [3] before the deadline of October 29, 2025, to discuss possible lead plaintiff appointments. Participation in the class action does not require appointment as a lead plaintiff, and there is no cost to investors.
The Schall Law Firm, the DJS Law Group, and Bronstein, Gewirtz & Grossman, LLC are experienced in securities class actions and shareholder rights litigation. They specialize in representing investors and recovering damages on behalf of those who have suffered losses due to securities fraud.
Semler Scientific is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934 and Rule 10b-5. The lawsuit claims the company made false and misleading statements to shareholders, including discussions about hypothetical violations of the False Claims Act without disclosing a DOJ investigation. Investors who purchased shares during the class period (March 10, 2021 to April 15, 2025) are encouraged to contact the firm about possible lead plaintiff appointments.
Semler Scientific, Inc. (NASDAQ: SMLR) is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934 and Rule 10b-5. The lawsuit, filed by several law firms, claims that the company made false and misleading statements to shareholders, including discussions about hypothetical violations of the False Claims Act without disclosing a Department of Justice (DOJ) investigation. Investors who purchased shares during the class period (March 10, 2021 to April 15, 2025) are encouraged to contact the firms involved to discuss their rights.According to the Complaint, Semler Scientific discussed potential violations of the False Claims Act in hypothetical terms during the class period but failed to disclose a DOJ investigation into such violations. This led to materially false and misleading statements, causing investors to suffer damages when the true details emerged. The class period for this lawsuit is from March 10, 2021, to April 15, 2025, inclusive.
Investors are urged to contact the Schall Law Firm [1], the DJS Law Group [2], and Bronstein, Gewirtz & Grossman, LLC [3] before the deadline of October 29, 2025, to discuss possible lead plaintiff appointments. Participation in the class action does not require appointment as a lead plaintiff, and there is no cost to investors.
The Schall Law Firm, the DJS Law Group, and Bronstein, Gewirtz & Grossman, LLC are experienced in securities class actions and shareholder rights litigation. They specialize in representing investors and recovering damages on behalf of those who have suffered losses due to securities fraud.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios